Pharming Group NV (OTCMKTS:PHGUF - Get Free Report) fell 0.9% on Monday . The company traded as low as $1.14 and last traded at $1.14. 5,000 shares changed hands during trading, The stock had previously closed at $1.15.
Pharming Group Stock Down 0.9%
The company has a market cap of $765.02 million, a P/E ratio of -114.00 and a beta of 0.65. The company has a debt-to-equity ratio of 0.51, a current ratio of 2.76 and a quick ratio of 2.00. The company's 50-day moving average is $1.14 and its two-hundred day moving average is $0.99.
Pharming Group Company Profile
(
Get Free Report)
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Recommended Stories
Before you consider Pharming Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharming Group wasn't on the list.
While Pharming Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access